Neuro-urology Department Florence, Spinal Unit, Spinal Unit Florence, Florence, Italy.
Spinal Cord. 2013 Jul;51(7):571-8. doi: 10.1038/sc.2013.37. Epub 2013 Apr 30.
To compare the efficacy of intravesical electrostimulation (IVES) versus sacral neuromodulation (SNM) in patients with incomplete spinal cord lesions (SCL) and neurogenic non-obstructive urinary retention (N-NOR).
In this retrospective study, 77 N-NOR patients underwent IVES (minimum 28 sessions), then after returning to voiding baseline symptoms, percutaneous first stage of SNM (lasting for minimum 4 weeks). After the two neuromodulation treatments, responders were categorized as patients experiencing both a 50% reduction of volume per catheterization per ml and a 50% reduction in number of catheterizations per day when comparing the 7-day voiding diaries at the end of both procedures to baselines. New urodynamics were performed subsequently. Responders to first stage of SNM underwent permanent SNM.
Forty-eight patients responded to neither of the treatments, whereas 29 responded to both IVES and first-stage SNM. No significant statistical differences (P>0.05) were detected in the voiding diaries. Following the two procedures, the first sensation of bladder filling was either maintained or recovered by all responders, whereas the same 11 patients reached a bladder contractility index of >100. The 29 IVES responders lost their clinical benefits in a mean follow-up of 9.6 months. Only 10 out of the 29 patients became nonresponsive to permanent SNM, in a mean follow-up of 54 months.
A strict correlation in terms of clinical and urodynamic patterns was demonstrated in patients with incomplete SCL and N-NOR, following IVES and first stage of SNM. However, voiding improvement through IVES was short-term when compared with the effects of permanent SNM.
比较经尿道电刺激(IVES)与骶神经调节(SNM)治疗不完全性脊髓损伤(SCL)伴神经源性非梗阻性尿潴留(N-NOR)患者的疗效。
在这项回顾性研究中,77 例 N-NOR 患者接受了IVES(至少 28 次)治疗,然后在恢复排尿基线症状后,进行经皮第一阶段 SNM(持续至少 4 周)。在这两种神经调节治疗后,将对两种治疗均有反应的患者定义为在结束这两种治疗后,与基线相比,7 天排尿日记中每次导尿尿量减少 50%,每天导尿次数减少 50%的患者。随后进行新的尿动力学检查。对第一阶段 SNM 有反应的患者接受永久性 SNM。
48 例患者对两种治疗均无反应,而 29 例患者对 IVES 和第一阶段 SNM 均有反应。在排尿日记中未检测到统计学差异(P>0.05)。在这两种治疗后,所有患者的膀胱充盈初始感觉得到保持或恢复,而 11 例患者的膀胱收缩力指数达到>100。29 例 IVES 反应者在平均 9.6 个月的随访中失去了临床获益。在平均 54 个月的随访中,只有 10 例患者对永久性 SNM 不再有反应。
在不完全性 SCL 伴 N-NOR 患者中,IVES 和第一阶段 SNM 后,在临床和尿动力学模式方面表现出严格的相关性。然而,与永久性 SNM 的效果相比,IVES 改善排尿是短期的。